Abnormal BMIPP uptake in chronically dysfunctional myocardial segments: Correlation with contractile response to low-dose dobutamine

Journal of Nuclear Medicine

Volumn 39, Issue 11, 1998, Pages 1845-1850

  Hambÿe, Anne Sophie E ^a   Vaerenberg, Marc M ^b   Dobbeleir, André A ^b   Van Den Heuvel, Paul A ^b   Franken, Philippe R ^b  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b NONE

Author keywords

Dobutamine stress echocardiography; Iodine 123 15 (p iodophenyl) 3 (R,S) methyl pentadecanoic acid; Myocardial viability; Old myocardial infarction; Technetium 99m sestamibi

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TRACER;

ADULT; AGED; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CORRELATION FUNCTION; DIAGNOSTIC ACCURACY; FEMALE; FUNCTIONAL ASSESSMENT; HEART INFARCTION; HEART LEFT VENTRICLE MUSCLE; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY;

ECHOCARDIOGRAPHY; FATTY ACIDS; FEMALE; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0031774253     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bonow R. Identification of viable myocardium. Circulation 1996;94:2674-2680.
2. Pierard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990;15:1021-1031.
3. Kayden DS, Sigal S, Soufer R, Mattera J, Zaret B, Wackers FTJ. Thallium-201 for assessment of myocardial viability: quantitative comparison of 24-hour redistribution imaging with imaging after reinjection at rest. J Am Coll Cardiol 1991;18:1480-1486.
4. Senior R, Raval U, Lahiri A. Technetium 99m-labeled sestamibi imaging reliably identifies retained contractile reserve in dyssynergic myocardial segments. J Nucl Cardiol 1995;2:296-302.
5. Marcassa C, Galli M, Cuocolo A, Scappellato F, Maurea S, Salvatore M. Rest-redistribution thallium-201 and rest technetium-99m-sestamibi SPECT in patients with stable coronary artery disease and ventricular dysfunction. J Nucl Med 1997;38:419-424.
6. 99mTc-sestamibi. Circulation 1994;89:2552-2561.
7. Sansoy V, Glover DK, Watson DD, et al. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability. Circulation 1995;92:994-1004.
8. 18F-fluorodeoxyglucose. Circulation 1994;89:578-587.
9. Altehoefer C, vom Dahl J, Biedermann M, et al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. Eur J Nucl Med 1994;35:569-574.
10. Dilsizian V, Perrone-Filardi P, Arrighi JA, et al. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography. Circulation 1993;88:941-952.
11. Sawada S, Allman K, Muzik O, et al. Positron emission tomography detects evidence of viability in rest technetium-99m-sestamibi defects. J Am Coll Cardiol 1994;23:92-98.
12. Schelbert HR. Blood flow and metabolism by PET. In: Verani MS, Crawford MH, eds. Cardiology Clinics. Nuclear Cardiology. Philadelphia, PA: WB Saunders; 1994:12: 303-315.
13. Tillisch JH, Brunken R, Marshall R, et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-888.
14. Knapp FF Jr, Ambrose KR, Goodman MM. New radioiodinated methyl branched fatty acids for cardiac studies. Eur J Nucl Med 1986;12(suppl):S39-S44.
15. Franken PR, De Geeter F, Dendale P, Demoor D, Block P, Bossuyt A. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 1994;35:1758-1765.
16. 123I-β-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 1994;21:283 291.
17. 201Tl-SPECT images. Eur J Nucl Med 1996;23:917-923.
18. Franken PR, Dendale P, De Geeter F, Demoor D, Bossuyt A, Block P. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 1996;37:718-722.
19. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992;33:659-667.
20. Tamaki N, Tadamura E, Kudoh T, et al. Prognostic value of iodine-123-labelled BMIPP fatty acid analogue in patients with myocardial infarction. Eur J Nucl Med 1996;23:272-279.
21. Mertens J, Eersels J, Van Ryckeghem W. New high yield Cu(I) assisted I-123 radioiodination of 15(p-I-phenyl)-9-methyl pentadecanoic acid, a potential myocardial tracer. Eur J Nucl Med 1987;13:159-160.
22. Van Steelandt E, Dobbeleir A, Vanregemorter J. Compton scatter correction for scintigraphic imaging. Proceedings of the 11th annual symposium of the Belgian Association of Hospital Physicists. Ghent, Belgium: University of Ghent; 1995:23.
23. Goresky CA, Stremmel W, Rose CP, et al. The capillary transport system for free fatty acids in the heart. Circ Res 1994;74:1015-1026.
24. Fujibayashi Y, Yonekura Y, Takemura Y, et al, Myocardial accumulation of iodinated beta-methyl branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methyl pentadecanoic acid (BMIPP) in relation to ATP concentration. J Nucl Med 1990;31:1818-1822.
25. Yamamichi Y, Kusuoka H, Morishita K, et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med 1995;36:1043-1050.
26. Fujiwara S, Takeishi Y, Atsumi H, Takahashi K, Tomoike H. Fatty acid metabolism imaging with iodine-123-BMIPP for the diagnosis of coronary artery disease. J Nucl Med 1997;38:175-180.
27. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451-1460.
28. Tateno M, Tamaki N, Yukihiro M, et al. Assessment of fatty acid uptake in ischemic heart disease without myocardial infarction. J Nucl Med 1996;37:1981-1985.
29. Arnese M, Cornel JH, Salustri A, et al. Prediction of improvement of regional left ventricular function after surgical revascularization. Circulation 1995;91:2748-2752.
30. McGillem MJ, DeBoe SF, Friedman HZ, Mancini GBJ. The effects of dopamine and dobutamine on regional function in the presence of rigid coronary stenoses and subcritical impairments of reactive hyperemia. Am Heart J 1988;115:970-977.
31. Sklenar J, Ismail S, Villanueva FS, Goodman NG, Glasheen WP, Kaul S. Dobutamine echocardiography for determining the extent of myocardial salvage after reperfusion. Circulation 1994;90:1502-1512.
32. Panza JA, Dilsizian V, Laurienzo JM, Curiel RV, Katsiyiannis PT. Relation between thallium uptake and contractile response to dobutamine: implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1995;91:990-998.
33. 201Tl scintigraphy and low dose dobutamine echocardiography for the noninvasive assessment of myocardial viability. Circulation 1996;94: 2681-2684.